insights_auto
Why is CADL down 3.57%?
Dive Deeperchevron_right
CADL:NASDAQ
Candel Therapeutics Inc
$5.13
arrow_downward
-3.57%(-0.19) 1D
$5.06
arrow_downward
-1.36% (-0.070)bedtimeAfter hours
Closed: Nov 19, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CADL...
Open
$5.38
High
$5.45
Low
$5.07
Mkt. cap
402.43M
Avg. vol.
1.40M
Volume
1.19M
52-wk high
$14.00
52-wk low
$4.35
EPS
-$1.49
Beta
-0.27
Shares outstanding
78.45M
No. of employees
55
Open
$5.38
High
$5.45
Low
$5.07
Mkt. cap
402.43M
Avg. vol.
1.40M
Volume
1.19M
52-wk high
$14.00
52-wk low
$4.35
EPS
-$1.49
Beta
-0.27
Shares outstanding
78.45M
No. of employees
55
News stories
From web sources and news partners
Investing.com
·
1 day ago
Candel Therapeutics at Jefferies Global Healthcare Conference: delay, data
GuruFocus
·
3 days ago
CADL Maintained by Citigroup -- Price Target Lowered to $20.00
Seeking Alpha
·
3 days ago
Candel Therapeutics: Upgrade Despite The Recent Prostate Filing Delay (NASDAQ:CADL)
TradingView
·
3 days ago
Weekly Recap: After-hours shares drop and Phase 3 AURORA enrollment begins
About Candel Therapeutics Inc
CEO-
Employees55
Founded2003
HeadquartersNeedham, Massachusetts, United States
SectorHealth Care
IndustryBiotechnology
Websitecandeltx.com